These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
671 related items for PubMed ID: 17259378
1. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model. Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H. Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378 [Abstract] [Full Text] [Related]
2. Deletion of protein kinase C-epsilon signaling pathway induces glomerulosclerosis and tubulointerstitial fibrosis in vivo. Meier M, Menne J, Park JK, Holtz M, Gueler F, Kirsch T, Schiffer M, Mengel M, Lindschau C, Leitges M, Haller H. J Am Soc Nephrol; 2007 Apr; 18(4):1190-8. PubMed ID: 17360953 [Abstract] [Full Text] [Related]
3. Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice. Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL. Diabetes; 2006 Nov; 55(11):3112-20. PubMed ID: 17065350 [Abstract] [Full Text] [Related]
4. Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S. Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1657-65. PubMed ID: 17804483 [Abstract] [Full Text] [Related]
5. Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. Menne J, Park JK, Boehne M, Elger M, Lindschau C, Kirsch T, Meier M, Gueler F, Fiebeler A, Bahlmann FH, Leitges M, Haller H. Diabetes; 2004 Aug; 53(8):2101-9. PubMed ID: 15277392 [Abstract] [Full Text] [Related]
6. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor. Russo LM, del Re E, Brown D, Lin HY. Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382 [Abstract] [Full Text] [Related]
7. Positive feedback loop between plasminogen activator inhibitor-1 and transforming growth factor-beta1 during renal fibrosis in diabetes. Seo JY, Park J, Yu MR, Kim YS, Ha H, Lee HB. Am J Nephrol; 2009 Feb; 30(6):481-90. PubMed ID: 19786738 [Abstract] [Full Text] [Related]
8. Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation. Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H. Diabetes; 2007 Feb; 56(2):363-72. PubMed ID: 17259380 [Abstract] [Full Text] [Related]
9. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Hamada Y, Fukagawa M. Kobe J Med Sci; 2007 Feb; 53(1-2):53-61. PubMed ID: 17582205 [Abstract] [Full Text] [Related]
10. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H. Auton Neurosci; 2003 Mar 28; 104(2):88-94. PubMed ID: 12648610 [Abstract] [Full Text] [Related]
11. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency. Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K. Kidney Int; 2005 Oct 28; 68(4):1583-9. PubMed ID: 16164635 [Abstract] [Full Text] [Related]
12. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy. Mizuno S, Nakamura T. Am J Physiol Renal Physiol; 2004 Jan 28; 286(1):F134-43. PubMed ID: 14519594 [Abstract] [Full Text] [Related]
13. Deletion of MK2 signalling in vivo inhibits small Hsp phosphorylation but not diabetic nephropathy. Park JK, Ronkina N, Höft A, Prohl C, Menne J, Gaestel M, Haller H, Meier M. Nephrol Dial Transplant; 2008 Jun 28; 23(6):1844-53. PubMed ID: 18182404 [Abstract] [Full Text] [Related]
14. High glucose induces macrophage inflammatory protein-3 alpha in renal proximal tubule cells via a transforming growth factor-beta 1 dependent mechanism. Qi W, Chen X, Zhang Y, Holian J, Mreich E, Gilbert RE, Kelly DJ, Pollock CA. Nephrol Dial Transplant; 2007 Nov 28; 22(11):3147-53. PubMed ID: 17664181 [Abstract] [Full Text] [Related]
15. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB. Am J Physiol Renal Physiol; 2009 Sep 28; 297(3):F729-39. PubMed ID: 19553350 [Abstract] [Full Text] [Related]
16. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Daniel C, Schaub K, Amann K, Lawler J, Hugo C. Diabetes; 2007 Dec 28; 56(12):2982-9. PubMed ID: 17878288 [Abstract] [Full Text] [Related]
17. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy. Jha JC, Thallas-Bonke V, Banal C, Gray SP, Chow BS, Ramm G, Quaggin SE, Cooper ME, Schmidt HH, Jandeleit-Dahm KA. Diabetologia; 2016 Feb 28; 59(2):379-89. PubMed ID: 26508318 [Abstract] [Full Text] [Related]
18. Influence of C-peptide on early glomerular changes in diabetic mice. Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y. Diabetes Metab Res Rev; 2006 Feb 28; 22(4):313-22. PubMed ID: 16389646 [Abstract] [Full Text] [Related]
19. [Effect of compound Rhizoma Coptidis capsule on expression of transforming growth factor-beta1 and type IV collagen proteins in renal tissue of diabetic rats with nephropathy]. Liu S, Tang LQ, Chen LM, Chen XQ, Zhang ST, Wei Y. Zhongguo Zhong Yao Za Zhi; 2008 Jan 28; 33(1):68-72. PubMed ID: 18338624 [Abstract] [Full Text] [Related]
20. Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats. Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, Arozal W, Sukumaran V, Lakshmanan AP, Arumugam S, Suzuki K. Mol Nutr Food Res; 2011 Nov 28; 55(11):1655-65. PubMed ID: 22045654 [Abstract] [Full Text] [Related] Page: [Next] [New Search]